Skip to main content
OpenTrials

Clinical trial condition

IgA Nephropathy

Explore clinical trials studying IgA Nephropathy. Study availability and eligibility vary by location and protocol.

79 public trials 16 recruiting studies
Refine in advanced search Browse all conditions

IgA Nephropathy trial results

Completed

Phase II Study Assessing Safety and Efficacy of APL-2 in Glomerulopathies

NCT03453619

Conditions
Autoimmune Diseases, C3 Glomerulonephritis, Connective Tissue Diseases, +18 more
Locations
  • Stanford University Stanford, California, United States
  • Children's Hospital Colorado Aurora, Colorado, United States
  • HealthONE Physician Care, Rocky Mountain Hospital for Children Denver, Colorado, United States
  • Washington Nephrology Associates Washington D.C., District of Columbia, United States
View all 17 locations
View Trial Details
Completed

Study of Safety and Efficacy of LNP023 in Patients With Kidney Disease Caused by Inflammation

NCT03373461

Conditions
Autoimmune Diseases, Chronic Disease, Disease Attributes, +15 more
Locations
  • Novartis Investigative Site Caba, Buenos Aires, Argentina
  • Novartis Investigative Site Ciudad Autonoma de Bs As, Buenos Aires, Argentina
  • Novartis Investigative Site Westmead, New South Wales, Australia
  • Novartis Investigative Site Parkville, Victoria, Australia
View all 56 locations
View Trial Details
Completed

The Effects of Mycophenolate Mofetil (MMF) on Renal Outcomes in Advanced Immunoglobulin A (IgA) Nephropathy Patients

NCT01854814

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Nanfang Hospital Southern Medical University Guangzhou, Guangdong, China
  • The Fourth People's Hospital Shenzhen Shenzhen, Guangdong, China
  • The Institute of Nephrology, Guangdong Medical College Zhanjiang, Guangdong, China
View Trial Details
Completed

Safety and Efficacy Study of Fostamatinib to Treat Immunoglobin A (IgA) Nephropathy

NCT02112838

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Stanford University Medical Palo Alto, California, United States
  • Nephrology Associates PC, University Hospital, Professional Center 1 Augusta, Georgia, United States
  • Ohio State University Columbus, Ohio, United States
  • Southeast Renal Research Institute Chattanooga, Tennessee, United States
View all 20 locations
View Trial Details
Completed

BRIGHT-SC: Blisibimod Response in IgA Nephropathy Following At-Home Treatment by Subcutaneous Administration

NCT02062684

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Investigator Site 852 Olomouc, Czechia
  • Investigator 851 Prague, Czechia
  • Investigator Site 905 Düsseldorf, Germany
  • Investigator Site 101 Hong Kong
View all 23 locations
View Trial Details

Related conditions